Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revelise vs Actilyse in STEMI
NCT07146360Phase 3Completed
- Sponsor
- Generium
- Start
- May 2014
- Primary completion
- Nov 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in myocardial infarction (MI), sponsored by Generium. Started May 2014; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT07146360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07146360.